Optimizing hepatitis B virus screening in the United States using a simple demographics‐based model. Issue 2 (7th December 2021)

• Record Type: Journal Article
• Authors: Ramrakhiani, Nathan S.; Chen, Vincent L.; Le, Michael; Yeo, Yee Hui; Barnett, Scott D.; Waljee, Akbar K.; Zhu, Ji; Nguyen, Mindie H.
• Is Part Of: Hepatology. Volume 75:Issue 2(2022)
• Page Start: 430
• Page End: 437
• Publication Date: 2021-12-07
• Subjects: Heart -- Diseases -- Nursing -- Periodicals; Lungs -- Diseases -- Nursing -- Periodicals; Intensive care nursing -- Periodicals; Foie -- Maladies -- Périodiques; 616.362
• DOI: 10.1002/hep.32142
• Languages: English
• ISSNs: 0270-9139

Abstract

Abstract: Background and Aims: Chronic hepatitis B (CHB) affects >290 million persons globally, and only 10% have been diagnosed, presenting a severe gap that must be addressed. We developed logistic regression (LR) and machine learning (ML; random forest) models to accurately identify patients with HBV, using only easily obtained demographic data from a population‐based data set. Approach and Results: We identified participants with data on HBsAg, birth year, sex, race/ethnicity, and birthplace from 10 cycles of the National Health and Nutrition Examination Survey (1999–2018) and divided them into two cohorts: training (cycles 2, 3, 5, 6, 8, and 10; n = 39, 119) and validation (cycles 1, 4, 7, and 9; n = 21, 569). We then developed and tested our two models. The overall cohort was 49.2% male, 39.7% White, 23.2% Black, 29.6% Hispanic, and 7.5% Asian/other, with a median birth year of 1973. In multivariable logistic regression, the following factors were associated with HBV infection: birth year 1991 or after (adjusted OR [aOR], 0.28; p < 0.001); male sex (aOR, 1.49; p = 0.0080); Black and Asian/other versus White (aOR, 5.23 and 9.13; p < 0.001 for both); and being USA‐born (vs. foreign‐born; aOR, 0.14; p < 0.001). We found that the ML model consistently outperformed the LR model, with higher area under the receiver operating characteristic values (0.83 vs. 0.75 in validation cohort; p < 0.001) and better differentiation of high‐ and low‐risk persons. Conclusions: Our ML model provides a simple, targeted approach to HBV screening, using only easily obtained demographic data.